Vanguard Group Inc Organovo Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 347,487 shares of ONVO stock, worth $118,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
347,487
Previous 353,612
1.73%
Holding current value
$118,145
Previous $268,000
33.96%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ONVO
# of Institutions
34Shares Held
2.44MCall Options Held
17KPut Options Held
0-
Armistice Capital, LLC New York, NY1.22MShares$414,1200.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK414KShares$140,7710.03% of portfolio
-
Black Rock Inc. New York, NY142KShares$48,3500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA125KShares$42,6620.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny44KShares$14,9690.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $2.96M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...